Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beriplex P/N versus plasma for urgent reversal of vitamin K antagonist-induced coagulopathy before emergency surgery
2007-007862-39Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jan 2009
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in warfarin-induced coagulopathy comparing Beriplex P/N with Plasma (2 arms). Primary endpoint: Hemostatic efficacy in preventing excessive hemorrhages during emergency surgical interventions. Started Jan 2009; status: completed.
02
Drugs
balfaxarFresh Frozen Plasma
03
Conditions
warfarin-induced coagulopathy
Beyond the preview
Go deeper on 2007-007862-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007862-39.